S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.10
+360.20
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
18.47
+1.79
+10.73%
IRTC · iRhythm Holdings, Inc.
NASDAQ NMS - GLOBAL MARKET - Real Time Price • USD
iRhythm Holdings, Inc (IRTC)
NASDAQ NMS - GLOBAL MARKET
Health Care
$113.63
-0.37
(-0.32%)
● At close: October 21 at 4:00:00 PM EDT
$113.31
-0.24
(-0.21%)
Pre-Market:
4:09:57 AM EDT
DAY'S RANGE
$113.63
$112.60
$115.48
52-WEEK RANGE
$113.63
$100.70
$212.00
What's happening
- IRTC is down 0.32% today, trading at $113.63. — Live quote
- Volume today (55,578) is well below its 3-month average of 576,970. (Finnhub fundamentals)
- Reports earnings on 2026-11-05, 14 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $0.58 actual vs. $-0.00 estimated (+12988.9%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 10
Buy 10
Hold 1
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (21 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
IRTC
-36.01%
vs S&P 500
-49.38%
1-YEAR RETURN
IRTC
-36.27%
vs S&P 500
-51.44%
6-MONTH RETURN
IRTC
-9.39%
3-MONTH RETURN
IRTC
+7.05%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$0.58
Est. $-0.00
BEAT +12988.9%
2026-04-26 (Q1 2026)
$-0.35
Est. $-0.66
BEAT +47.1%
2026-01-26 (Q4 2025)
$0.29
Est. $0.03
BEAT +735.7%
2025-10-26 (Q3 2025)
$-0.06
Est. $-0.32
BEAT +81.0%
Valuation Measures & Ratios
Enterprise Value4$4.13B
Forward P/E5110.33
PEG Ratio6—
Price / Sales (TTM1)4.52
Price / Book721.02
EV4 / Revenue5.01
EV4 / EBITDA—
Profit Margin-1.69%
Operating Margin-3.01%
Return on Equity (ROE8)-8.97%
Return on Assets (ROA9)-1.36%
Avg Volume (3M)576,970
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $4.53B | $3.83B | $5.61B | $4.98B | $3.31B |
| P/E | -134.27 | -59.73 | -58.20 | -44.79 | -23.18 |
| Price/Sales | 5.64 | 5.19 | 8.17 | 7.77 | 5.64 |
| Price/Book | 24.36 | 23.74 | 45.99 | 48.05 | 38.15 |
| EV/Revenue | 5.33 | 4.86 | 7.80 | 7.29 | 5.00 |
| EV/EBITDA | -168.91 | -64.76 | -59.85 | — | — |
| ROE | -18.14% | -39.74% | -79.01% | -107.28% | -164.61% |
| ROA | -3.09% | -6.37% | -9.68% | -11.54% | -15.40% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short3,033,358
Change from Prior Settlement-0.71%
% of Float—
Days to Cover (Short Ratio)5.85
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 20.1% on the provider's reported measure. Finnhub fundamentals ↗
- Latest SEC filing is Form 8-K, filed 2026-10-05; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Net profit margin is -1.7%. Finnhub fundamentals ↗
- Trailing 52-week price return is -36.3%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on IRTC
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $224.2M | $199.4M | $192.9M | $186.7M | $158.7M | $147.5M | $148.0M | $131.9M |
| Gross profit | $163.2M | $141.4M | $137.1M | $132.9M | $109.2M | $101.5M | $103.5M | $87.5M |
| Operating income | -$2.5M | -$16.2M | -$8.4M | -$18.7M | -$32.6M | -$50.3M | -$23.0M | -$38.1M |
| Net income | -$381.0K | -$13.9M | -$5.2M | -$14.2M | -$30.7M | -$46.2M | -$20.1M | -$45.7M |
| EPS (diluted) | $-0.01 | $-0.43 | $-0.16 | $-0.44 | $-0.97 | $-1.48 | $-0.65 | $-1.47 |
| EPS (basic) | $-0.01 | $-0.43 | $-0.16 | $-0.44 | $-0.97 | $-1.48 | $-0.65 | $-1.47 |
| Operating margin | -$1 | -$8 | -$4 | -$10 | -$21 | -$34 | -$16 | -$29 |
| Net margin | -$0 | -$7 | -$3 | -$8 | -$19 | -$31 | -$14 | -$35 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $1.09B | $1.01B | $1.02B | $995.2M | $964.0M | $926.1M | $931.4M | $909.7M |
| Total liabilities | $907.4M | $845.2M | $867.3M | $873.3M | $860.4M | $839.4M | $840.5M | $837.9M |
| Stockholders' equity | $186.0M | $161.2M | $152.7M | $121.9M | $103.7M | $86.7M | $90.9M | $71.8M |
| Total current assets | $756.0M | $680.6M | $702.8M | $680.0M | $663.9M | $636.0M | $645.8M | $627.9M |
| Total current liabilities | $196.1M | $131.8M | $151.9M | $146.9M | $132.2M | $111.3M | $110.9M | $100.1M |
| Cash & equivalents | $246.7M | $240.1M | $236.0M | $255.6M | $309.1M | $375.3M | $419.6M | $519.5M |
| Marketable securities (current) | $344.6M | $309.5M | $347.8M | $309.6M | $236.4M | $145.3M | $116.0M | $2.5M |
| Accounts receivable | $84.3M | $80.9M | $75.7M | $76.2M | $82.2M | $80.6M | $79.9M | $77.4M |
| Inventory | $22.5M | $23.8M | $21.6M | $19.6M | $18.4M | $14.3M | $14.0M | $15.0M |
| Marketable securities (non-current) | $73.7M | $72.9M | $69.9M | $68.1M | $64.9M | $62.7M | $61.9M | $59.1M |
| Property, plant & equipment | $165.3M | $156.7M | $151.6M | $149.3M | $139.7M | $130.8M | $125.1M | $122.4M |
| Goodwill | $862.0K | $862.0K | $862.0K | $862.0K | $862.0K | $862.0K | $862.0K | $862.0K |
| Other non-current assets | $50.5M | $46.7M | $44.7M | $45.3M | $41.5M | $41.1M | $41.9M | $45.5M |
| Accounts payable | $17.4M | $8.6M | $2.3M | $8.3M | $12.8M | $11.9M | $7.2M | $7.6M |
| Accrued liabilities | $157.6M | $102.3M | $128.7M | $117.9M | $99.6M | $80.0M | $84.9M | $74.0M |
| Deferred revenue (current) | $4.2M | $4.1M | $4.2M | $4.2M | $3.5M | $3.3M | $2.9M | $3.0M |
| Short-term debt | — | — | — | — | — | — | — | — |
| Long-term debt | — | — | — | — | — | — | — | — |
| Other non-current liabilities | $908.0K | $907.0K | $908.0K | $9.9M | $9.8M | $8.7M | $8.6M | $18.0M |
| Common stock & paid-in capital | $33.0K | $33.0K | $32.0K | $32.0K | $32.0K | $32.0K | $31.0K | $31.0K |
| Retained earnings | -$817.8M | -$817.4M | -$803.4M | -$809.0M | -$803.8M | -$789.6M | -$758.9M | -$757.6M |
| Accumulated other comprehensive income (loss) | -$188.0K | $42.0K | $403.0K | $285.0K | -$26.0K | $143.0K | $165.0K | -$66.0K |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $51.1M | -$26.2M | $26.2M | $34.9M | $27.7M | -$7.9M | $19.2M | $24.3M |
| Investing cash flow | -$48.6M | $30.2M | -$48.8M | -$89.2M | -$100.9M | -$38.1M | -$122.2M | -$55.3M |
| Financing cash flow | $4.1M | $149.0K | $3.0M | $825.0K | $7.1M | $1.7M | $3.0M | -$35.0K |
| Free cash flow | $37.5M | -$33.1M | $14.5M | $20.1M | $17.3M | -$17.3M | $12.4M | $15.5M |
| Capital expenditures | $13.6M | $6.9M | $11.7M | $14.8M | $10.4M | $9.4M | $6.8M | $8.8M |
| Depreciation & amortization | $5.2M | $5.0M | $15.5M | $5.2M | $5.1M | $5.2M | $15.6M | $5.1M |
| Share-based compensation | $20.0M | $21.5M | $21.1M | $21.0M | $22.8M | $23.3M | $16.0M | $17.2M |
| Deferred income taxes | — | — | $118.0K | — | — | — | -$127.0K | — |
| Change in accounts receivable | $33.0M | $33.0M | $19.1M | $19.5M | $26.8M | $30.1M | $23.2M | $9.2M |
| Change in inventory | -$1.2M | $2.4M | $2.1M | $1.8M | $4.2M | $388.0K | -$817.0K | -$425.0K |
| Change in accounts payable | $64.8M | -$22.5M | -$1.6M | $15.0M | $15.2M | -$489.0K | $971.0K | $2.3M |
| Purchases of investments | $160.4M | $94.0M | $125.6M | $171.1M | $135.1M | $34.3M | $115.8M | $0 |
| Sales/maturities of investments | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | $0 | $0 | $0 | $0 | $0 | $0 |
| Debt issued | — | — | — | — | — | — | — | — |
| Debt repaid | — | — | — | — | — | — | — | — |
| Tax withholding on stock comp | — | — | — | — | — | — | — | — |
| Other financing activities | — | — | — | — | — | — | — | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $747.1M | $591.8M | $492.7M | $410.9M | $322.8M |
| Gross profit | $527.2M | $407.5M | $331.8M | $281.6M | $213.6M |
| Operating income | -$57.4M | -$115.5M | -$125.2M | -$113.8M | -$99.9M |
| Net income | -$44.6M | -$113.3M | -$123.4M | -$116.2M | -$101.4M |
| EPS (diluted) | $-1.39 | $-3.63 | $-4.04 | $-3.88 | $-3.46 |
| EPS (basic) | $-1.39 | $-3.63 | $-4.04 | $-3.88 | $-3.46 |
| Operating margin | -$8 | -$20 | -$25 | -$28 | -$31 |
| Net margin | -$6 | -$19 | -$25 | -$28 | -$31 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $1.02B | $931.4M | $433.1M | $448.2M | $463.0M |
| Total liabilities | $867.3M | $840.5M | $223.0M | $208.4M | $183.5M |
| Stockholders' equity | $152.7M | $90.9M | $210.1M | $239.8M | $279.5M |
| Total current assets | $702.8M | $645.8M | $230.8M | $288.8M | $305.5M |
| Total current liabilities | $151.9M | $110.9M | $107.4M | $89.1M | $87.9M |
| Cash & equivalents | $236.0M | $419.6M | $36.2M | $78.8M | $127.6M |
| Marketable securities (current) | $347.8M | $116.0M | $97.6M | $134.3M | $111.6M |
| Accounts receivable | $75.7M | $79.9M | $61.5M | $49.9M | $46.4M |
| Inventory | $21.6M | $14.0M | $14.0M | $15.2M | $10.3M |
| Marketable securities (non-current) | $69.9M | $61.9M | $3.0M | — | — |
| Property, plant & equipment | $151.6M | $125.1M | $104.1M | $75.7M | $55.9M |
| Goodwill | $862.0K | $862.0K | $862.0K | $862.0K | $862.0K |
| Other non-current assets | $44.7M | $41.9M | $45.0M | $22.3M | $16.1M |
| Accounts payable | $2.3M | $7.2M | $5.5M | $7.5M | $10.5M |
| Accrued liabilities | $128.7M | $84.9M | $83.4M | $65.5M | $51.5M |
| Deferred revenue (current) | $4.2M | $2.9M | $3.3M | $3.1M | $3.0M |
| Short-term debt | — | — | — | — | — |
| Long-term debt | — | — | $35.0M | $34.9M | $9.7M |
| Other non-current liabilities | $908.0K | $8.6M | $1.0M | $1.3M | $697.0K |
| Common stock & paid-in capital | $32.0K | $31.0K | $31.0K | $28.0K | $27.0K |
| Retained earnings | -$803.4M | -$758.9M | -$645.6M | -$522.2M | -$406.0M |
| Accumulated other comprehensive income (loss) | $403.0K | $165.0K | -$112.0K | -$396.0K | -$61.0K |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | $80.9M | $3.4M | -$50.1M | -$23.0M | -$37.8M |
| Investing cash flow | -$277.1M | -$123.0M | -$1.2M | -$52.4M | $105.3M |
| Financing cash flow | $12.6M | $511.4M | $8.8M | $26.7M | -$28.6M |
| Free cash flow | $34.5M | -$30.6M | -$90.5M | -$52.8M | -$65.8M |
| Capital expenditures | $46.3M | $33.9M | $40.4M | $29.8M | $28.1M |
| Depreciation & amortization | $20.7M | $20.7M | $16.3M | $13.4M | $9.8M |
| Share-based compensation | $88.3M | $76.0M | $77.2M | $57.7M | $54.5M |
| Deferred income taxes | $118.0K | -$127.0K | $0 | -$2.0K | -$6.0K |
| Change in accounts receivable | $95.4M | $91.9M | $81.2M | $61.8M | $53.6M |
| Change in inventory | $8.5M | $224.0K | -$979.0K | $5.1M | $5.0M |
| Change in accounts payable | $28.0M | -$7.4M | $17.3M | $11.5M | $6.1M |
| Purchases of investments | $466.1M | $118.2M | $164.3M | $188.6M | $122.2M |
| Sales/maturities of investments | — | — | — | — | $0 |
| Share repurchases | $0 | $25.0M | $0 | $0 | — |
| Debt issued | — | — | — | — | — |
| Debt repaid | — | — | $0 | $21.4M | $11.7M |
| Tax withholding on stock comp | — | — | $0 | $0 | $25.9M |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding IRTC as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-05-11 to 2026-09-02
Recent transactions
- Insiders have net sold 64,510 shares over the last 182 days, across 1 purchase and 18 sales.
- Most recent: Wilson Daniel G. (Chief Financial Officer) — Open market sale of 773 shares on 2026-09-02.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)5,312 sh(1 txns)
Sales (open market)69,822 sh(18 txns)
Net Shares-64,510
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Wilson Daniel G. | Chief Financial Officer | Open market sale | 2026-09-02 | 773 |
| Blackford Quentin S. | President and CEO | Open market sale | 2026-08-10 | 26,859 |
| Murphy Patrick Michael | CBO and CLO | Open market sale | 2026-08-10 | 7,093 |
| Patterson Chad | CHIEF COMM & PRODUCT OFFICER | Open market sale | 2026-08-10 | 7,093 |
| Shrishrimal Sumi | EVP, Chief Risk Officer | Open market sale | 2026-08-10 | 5,372 |
| Turakhia Minang | CHIEF MED/SCI OFCR EVP ADVTECH | Open market sale | 2026-08-10 | 7,093 |
| Smith Mervin | EVP Strategic Business Ops | Open market sale | 2026-08-03 | 617 |
| Rodda Julianne | EVP, CHIEF PEOPLE OFFICER | Open market sale | 2026-08-03 | 2,112 |
| Freeman Sean Clinton | EVP, Strategy & Corp Devt | Open market sale | 2026-07-02 | 918 |
| Rosenbaum Marc Wade | Chief Accounting Officer | Open market sale | 2026-06-02 | 729 |
| Bairey Merz Cathleen Noel | Director | Grant / award | 2026-05-27 | 1,573 |
| Bodaken Bruce G. | Director | Grant / award | 2026-05-27 | 1,573 |
| Ling Karen | Director | Grant / award | 2026-05-27 | 1,573 |
| MCGINNIS KAREN K | Director | Grant / award | 2026-05-27 | 1,573 |
| OBOYLE KEVIN C | Director | Grant / award | 2026-05-27 | 1,573 |
| TALWALKAR ABHIJIT Y | Director | Grant / award | 2026-05-27 | 1,573 |
| YOOR BRIAN B | Director | Grant / award | 2026-05-27 | 1,573 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-02 | Wilson Daniel G. | Chief Financial Officer | Open market sale | 773 | $121.83 |
| 2026-08-10 | Blackford Quentin S. | President and CEO | Open market sale | 26,859 | $124.65 |
| 2026-08-10 | Murphy Patrick Michael | CBO and CLO | Open market sale | 7,093 | $124.65 |
| 2026-08-10 | Patterson Chad | CHIEF COMM & PRODUCT OFFICER | Open market sale | 7,093 | $124.65 |
| 2026-08-10 | Shrishrimal Sumi | EVP, Chief Risk Officer | Open market sale | 5,372 | $124.65 |
| 2026-08-10 | Turakhia Minang | CHIEF MED/SCI OFCR EVP ADVTECH | Open market sale | 7,093 | $124.65 |
| 2026-08-07 | Blackford Quentin S. | President and CEO | Grant / award | 48,534 | $0.00 |
| 2026-08-07 | Murphy Patrick Michael | CBO and CLO | Grant / award | 13,589 | $0.00 |
| 2026-08-07 | Patterson Chad | CHIEF COMM & PRODUCT OFFICER | Grant / award | 13,589 | $0.00 |
| 2026-08-07 | Shrishrimal Sumi | EVP, Chief Risk Officer | Grant / award | 9,706 | $0.00 |
| 2026-08-07 | Turakhia Minang | CHIEF MED/SCI OFCR EVP ADVTECH | Grant / award | 13,589 | $0.00 |
| 2026-08-03 | Smith Mervin | EVP Strategic Business Ops | Open market sale | 617 | $122.12 |
| 2026-08-03 | Rodda Julianne | EVP, CHIEF PEOPLE OFFICER | Open market sale | 2,112 | $122.12 |
| 2026-08-03 | Patterson Chad | CHIEF COMM & PRODUCT OFFICER | Open market sale | 2,712 | $122.12 |
| 2026-07-02 | Turakhia Minang | CHIEF MED/SCI OFCR EVP ADVTECH | Open market sale | 1,423 | $124.71 |
| 2026-07-02 | Freeman Sean Clinton | EVP, Strategy & Corp Devt | Open market sale | 918 | $124.71 |
| 2026-06-02 | Shrishrimal Sumi | EVP, Chief Risk Officer | Open market sale | 1,716 | $108.19 |
| 2026-06-02 | Rosenbaum Marc Wade | Chief Accounting Officer | Open market sale | 729 | $108.19 |
| 2026-05-29 | Shrishrimal Sumi | EVP, Chief Risk Officer | Grant / award | 133 | $96.81 |
| 2026-05-29 | Rosenbaum Marc Wade | Chief Accounting Officer | Grant / award | 178 | $96.81 |
| 2026-05-29 | Turakhia Minang | CHIEF MED/SCI OFCR EVP ADVTECH | Grant / award | 137 | $96.81 |
| 2026-05-29 | Patterson Chad | CHIEF COMM & PRODUCT OFFICER | Grant / award | 177 | $96.81 |
| 2026-05-29 | Freeman Sean Clinton | EVP, Strategy & Corp Devt | Grant / award | 273 | $96.81 |
| 2026-05-29 | Blackford Quentin S. | President and CEO | Grant / award | 178 | $96.81 |
| 2026-05-27 | Bairey Merz Cathleen Noel | Director | Grant / award | 1,573 | $0.00 |
| 2026-05-27 | Bodaken Bruce G. | Director | Grant / award | 1,573 | $0.00 |
| 2026-05-27 | Ling Karen | Director | Grant / award | 1,573 | $0.00 |
| 2026-05-27 | MCGINNIS KAREN K | Director | Grant / award | 1,573 | $0.00 |
| 2026-05-27 | OBOYLE KEVIN C | Director | Grant / award | 1,573 | $0.00 |
| 2026-05-27 | TALWALKAR ABHIJIT Y | Director | Grant / award | 1,573 | $0.00 |
| 2026-05-27 | YOOR BRIAN B | Director | Grant / award | 1,573 | $0.00 |
| 2026-05-11 | TALWALKAR ABHIJIT Y | Director | Open market purchase | 5,312 | $10.71 |
| 2026-05-11 | TALWALKAR ABHIJIT Y | Director | Open market sale | 940 | $116.05 |
| 2026-05-11 | TALWALKAR ABHIJIT Y | Director | Open market sale | 642 | $116.98 |
| 2026-05-11 | TALWALKAR ABHIJIT Y | Director | Open market sale | 2,293 | $118.02 |
| 2026-05-11 | TALWALKAR ABHIJIT Y | Director | Open market sale | 1,147 | $119.16 |
| 2026-05-11 | TALWALKAR ABHIJIT Y | Director | Open market sale | 290 | $120.53 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 06:31 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-05 | 8-K | 2026-10-05 | View on SEC.gov → |
| 2026-09-22 | 8-K | 2026-09-22 | View on SEC.gov → |
| 2026-09-03 | 4 | 2026-09-02 | View on SEC.gov → |
| 2026-08-13 | 8-K | 2026-08-11 | View on SEC.gov → |
| 2026-08-11 | 4 | 2026-08-07 | View on SEC.gov → |
| 2026-08-11 | 4 | 2026-08-07 | View on SEC.gov → |
| 2026-08-11 | 4 | 2026-08-07 | View on SEC.gov → |
| 2026-08-11 | 4 | 2026-08-07 | View on SEC.gov → |
| 2026-08-11 | 4 | 2026-08-07 | View on SEC.gov → |
| 2026-08-06 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-06 | 8-K | 2026-08-05 | View on SEC.gov → |
| 2026-08-06 | 8-K | 2026-07-31 | View on SEC.gov → |
Recent news
Headlines about IRTC (iRhythm Holdings, Inc.). Links open the publisher — we don’t host full articles.
-
iRhythm Holdings Inc (IRTC) Stock Up 3.9% and Still Undervalued -- GF Score: 81/100
GuruFocus · 2026-10-20 -
Here's How Tempus AI Demonstrates Improving Operating Leverage
Yahoo · 2026-10-19 -
Cybersecurity Breach Might Change The Case For Investing In iRhythm Stock (IRTC)
Simply Wall Street · 2026-10-19 -
iRhythm (IRTC) Stock Sees Modest Fair Value Cut After VitalConnect And Zio MCT Questions
Yahoo · 2026-10-18 -
Is iRhythm Holdings (IRTC) Undervalued After Its Share Price Pullback?
Yahoo · 2026-10-18 -
iRhythm Holdings (IRTC) Stock May Be A Bargain After Data Breach Probe
Yahoo · 2026-10-17 -
Piper Sandler initiates coverage of iRhythm Holdings with Overweight rating, $160 price target
TradingView · 2026-10-16 -
iRhythm Holdings (IRTC) Stock Rises on Piper Sandler Overweight Rating and $160 Price Target
GuruFocus · 2026-10-16
No headlines in this category right now — try “All”.